|
|
FY 2019 |
FY 2018 PF |
Profit attributable to Solvay share (in € m) |
|
|
|
Underlying profit for the period |
a |
1,075 |
1,085 |
Underlying profit from continuing operations |
b |
828 |
869 |
IFRS profit for the period |
c |
118 |
871 |
IFRS profit from continuing operations |
d |
(118) |
670 |
Number of shares (in 1000 shares) |
|
|
|
Issued shares at end of year |
e |
105,876 |
105,876 |
Treasury shares at end of year |
f |
2,466 |
2,723 |
Outstanding shares at the end of the year |
g = e-f |
103,411 |
103,154 |
Average outstanding shares (basic calculation) |
h |
103,177 |
103,277 |
Average outstanding shares (diluted calculation) |
i |
103,403 |
103,735 |
Data per share (in €) |
|
|
|
Underlying profit for the period (basic) |
j = a/h |
10.41 |
10.51 |
Underlying profit from continuing operations (basic) |
k = b/h |
8.02 |
8.42 |
IFRS profit for the period (basic) |
l = c/h |
1.15 |
8.43 |
IFRS profit from continuing operations (basic) |
m = d/h |
(1.14) |
6.49 |
IFRS profit for the period (diluted) |
p = c/i |
1.15 |
8.40 |
IFRS profit from continuing operations (diluted) |
q = d/i |
(1.14) |
6.46 |
Underlying earnings per share[10] from continuing operations were down -4.7% at €8.02. Higher depreciation and amortization charges and the slightly lower EBITDA were mitigated by lower net financial charges, following the repayment of higher interest-yielding debt in June 2018 and May 2019. Total underlying earnings per share in the full year was modestly down thanks to a higher contribution from the discontinued polyamide operations.
[10] Earnings per share basis calculation